Drawing for NOSTER

USPTO serial 79202442

NOSTER

Reviewed by CopyMark Law Group

Reg. 5319552Status 709
Filing date
Status date
Registration date
Oct 31, 2017
Examiner
TWOHIG, SHANNON MARIE
Law office
TMO LAW OFFICE 121

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with NOSTER?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
001Lactic acid bacteria powder for producing food, dietary supplements for humans or beverages; biological microorganisms for producing food, dietary supplements for humans or beverages; chemical additives for use in the manufacture of food, pharmaceuticals, cosmetics and animal feed; perfluorinated chemical compounds prepared synthetically for use in the manufacture of cosmetics and pharmaceuticals; food preserving chemicals; chemical preparations for preserving foodstuffs; chemical products for the fresh-keeping and preserving of food; chemical products for stabilizing foodstuffs; chemicals for industrial purposes; chemicals for use in the manufacture of a wide variety of goods; glue and adhesives for industrial purposes; plant growth regulating preparations; fertilizers; higher fatty acids for industrial purposes; unprocessed plastic; gluten for the food industrySECTION 71 - CANCELLED—
003Cosmetics; deodorant soaps and laundry detergents; dentifrices; perfume and flavour materials, namely, natural perfumery prepared from vegetables, natural perfumery prepared from animals, synthetic perfumery, blended perfumery and food flavorings prepared from essential oils; false nails; false eyelashes; breath freshening preparations; deodorants for animals; incenses and fragrancesSECTION 71 - CANCELLED—
005Pharmaceutical preparations other than for agricultural purposes for the treatment and prevention of metabolic and endocrine diseases, namely, diabetes, diabetic complication, hyperlipidemia, hyperuricemia, gout, lifestyle related disease, nutritional disorders, impaired glucose tolerance, metabolic syndrome, obesity and lipid disorder, cardiovascular, urological and reproductive diseases, namely, hypertension, hyperglycemia, ischemic heart disease, hyperinsulinemia, arteriosclerosis, myocardial infarction, angina pectoris, aneurysm, chronic kidney disease, renal calculi, kidney disease, pyelonephritis, nephritis, urethritis, cystitis, hypercholesterolemia and high triglyceridemia, respiratory diseases, namely, bronchitis, pulmonary emphysema and lung inflammation, digestive and oral diseases, namely, abnormality of the intestinal flora, abdominal distension, peptic ulcer, intestinal disease, inflammatory disorder, irritable bowel syndrome, gastric ulcer, inflammatory bowel disease, Crohn's disease, diverticulitis, liver cirrhosis, fatty liver, diarrhea, constipation, loose stool disease, hepatic inflammation, non-alcoholic steatohepatitis, viral hepatitis, alcoholic hepatitis, dental disease, periodontal diseases, stomatitis, xerostomia and cyst, immune, inflammatory and allergic diseases, namely, immune related diseases and abnormalities, type I, II, III, IV and V allergy, pollinosis, atopic dermatitis, psoriasis, autoimmune disease and connective tissue disease, bone and articular diseases, namely, rheumatism, osteoporosis and articular inflammation, pathogenic microbial and malignant neoplastic diseases, namely, infection, cancer and malignant tumor, mental and nervous system diseases, namely, mental disorder, dementia, Alzheimer's disease, bipolar disorder, depression, anorexia, insomnia, cerebral apoplexy, cerebral infarction, autism, neuroinflammation, overwork related disease and nerve inflammation related diseases and cancers resulting from chronic inflammation, and sensory system and skin diseases, namely, ophthalmic disease, ocular inflammation, otorhinolaryngology disease and skin inflammation; pharmaceutical preparations in the nature of medicines for dental purposes; reagent paper for medical purposes; oiled paper for medical purposes; drug delivery agents in the form of edible wrapping wafers for medicine doses; gauze for dressings; empty capsules for pharmaceuticals; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton for medical purposes; adhesive plasters for medical purposes; bandages for dressings; liquid bandages; breast-nursing pads; cotton swabs for medical use; dental composite, impression and porcelain materials; dental materials, namely, dental porcelain materials, materials for making dental impressions and composite materials for dental and dental technical purposes; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies; food for babies; dietary supplements for animalsSECTION 71 - CANCELLED—
029Milk products excluding ice cream, ice milk, and frozen yogurt; edible oils and fats; fresh, chilled or frozen meat for human consumption; fresh, chilled or frozen edible aquatic animals not live; processed meat products; processed seafood products other than blocks of boiled, smoked and then dried bonitos (Katsuo-bushi), dried pieces of agar jelly (Kanten), flakes of dried fish meat (Kezuri-bushi), fishmeal for human consumption, edible shavings of dried kelp (Tororo-kombu), sheets of dried laver (Hoshi-nori), dried brown alga (Hoshi-hijiki), dried edible seaweed (Hoshi-wakame) and toasted sheets of laver (Yaki-nori), namely, tinned seafood, processed fish; processed vegetables and fruits; protein for use as a food additive, namely, formed textured vegetable protein for use as a meat substitute and textured vegetable protein for use as a meat extenderSECTION 71 - CANCELLED—
030Tea; roasted, powdered or granulated coffee; coffee beverages; roasted, powdered or granulated cocoa; cocoa beverages; Japanese traditional confectionery; western-style confectionery; bread and buns; sandwiches; steamed buns stuffed with minced meat (Chuka-manjuh); hamburger sandwiches; pizzas; hot dog sandwiches; meat pies; cube sugar; fructose for culinary purposes; crystal sugar, not confectionery; sugar; maltose for culinary purposes; honey; glucose for culinary purposes; powdered starch syrup for culinary purposes; starch syrup for culinary purposes; ice cream mixes; sherbet mixes; flourSECTION 71 - CANCELLED—
032Whey beverages; carbonated non-alcoholic drinks; fruit juices; vegetable juice; beer; extracts of hops for making beerSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 26, 2025INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Apr 7, 2025INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Apr 7, 2025INPCINVALIDATION PROCESSED—
Jan 18, 2025INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 17, 2024C71TCANCELLED SECTION 71—
Oct 31, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Oct 23, 2020CHLDCHANGE OF OWNER RECEIVED FROM IB—
Apr 13, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 8, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 8, 2018FIMPFINAL DISPOSITION PROCESSED—
Feb 6, 2018COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Feb 6, 2018APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 31, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jan 10, 2018ES7RTEAS SECTION 7 REQUEST RECEIVED—
Oct 31, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2017GPNXNOTIFICATION PROCESSED BY IB—
Aug 15, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 8, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 22, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 22, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 13, 2017ALIEASSIGNED TO LIE—
May 19, 2017TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 19, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2017RFNTREFUSAL PROCESSED BY IB—
Mar 7, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 7, 2017RFRRREFUSAL PROCESSED BY MPU—
Mar 7, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 4, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 3, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 3, 2017DOCKASSIGNED TO EXAMINER—
Mar 3, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 2, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance